Healx
Healx is a Cambridge, UK clinical-stage biotechnology company that uses artificial intelligence to discover and develop new treatments for rare diseases. Its Healnet platform pairs generative AI with drug-discovery and rare-disease expertise to build a biomedical knowledge graph from public and proprietary sources - biomedical literature, disease and biochemical datasets, clinical trials and patents - and to identify novel uses for known compounds. Founded by David Brown and Tim Guilliams, Healx advances its own therapeutic pipeline (including its NF1 lead candidate HLX-1502) and partners with pharma companies such as Sanofi. Healx does not currently publish a public developer API; this profile tracks its identity and public web surface in the API Evangelist network.
Healx is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Drug Discovery, Rare Diseases, and Biotechnology.
Healx’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API